董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Shirley A. Weis Director 71 23.88万美元 未持股 2025-07-01
Guy P. Sansone Lead Independent Director 60 25.76万美元 未持股 2025-07-01
Thomas A. McEachin Director 72 23.41万美元 未持股 2025-07-01
John M. Starcher, Jr. Director 54 23.41万美元 未持股 2025-07-01
Mark S. Ordan Chair of the Board and Chief Executive Officer 66 643.87万美元 未持股 2025-07-01
Laura Linynsky Director 57 未披露 未持股 2025-07-01
Sylvia J. Young Director 63 未披露 未持股 2025-07-01
Kurt Newman Director -- 未披露 未持股 2025-07-01
Michael A. Rucker Director 55 18.19万美元 未持股 2025-07-01

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Mark S. Ordan Chair of the Board and Chief Executive Officer 66 643.87万美元 未持股 2025-07-01
Kasandra H. Rossi Executive Vice President, Chief Financial Officer and Treasurer 52 未披露 未持股 2025-07-01
Mary Ann E. Moore Executive Vice President, General Counsel, Chief Administrative Officer and Secretary 65 未披露 未持股 2025-07-01

董事简历

中英对照 |  中文 |  英文
Shirley A. Weis

Shirley A. Weis,自2020年7月起担任公司董事。她曾担任Weis Associates, LLC(她创立的咨询公司,专注于医疗保健管理、战略规划和领导力发展)的总裁(2014年1月以来)。此前,她曾担任Mayo Clinic(一家非营利性医疗实践和医学研究集团)的副总裁兼首席行政官(从2007年到2013年12月退休)。她于1995年加入梅奥诊所,担任多个临床和行政领导职位,包括亚利桑那州梅奥诊所行政服务主席、梅奥诊所管理护理部门主席和梅奥管理服务公司的执行董事。她还曾担任梅奥诊所董事会成员。2017年7月至2021年12月,她担任Obyx(前身为the Medical Memory, LLC)的董事会成员,这是一家总部位于Phoenix的私人公司,促进与医生的医疗对话记录并将其分发给患者和家属。2015年5月至2019年4月,她曾担任Sentry Insurance Company(一家专门从事商业保险的互助保险公司)和Surgalign Holdings, Inc.(前身为RTI Surgical Holdings, Inc.) (OTC: SRGAQ)的董事会成员,这是一家推进脊柱护理科学的全球医疗技术公司,从2014年10月至2021年5月。她持有Michigan State大学的理学士学位、阿奎那学院(Aquinas College)的管理硕士学位和Michigan State大学的荣誉理学博士学位。2007年和2013年,她被《现代医疗》杂志评为25位医疗行业女性之一。


Shirley A. Weis,has been a Director of the Company since July 2020. Ms. Weis has served as the President of Weis Associates, LLC, a consulting firm she founded focused on healthcare management, strategic planning and leadership development, since January 2014. Previously, Ms. Weis was the Vice President and Chief Administrative Officer of Mayo Clinic, a nonprofit medical practice and medical research group, from 2007 until her retirement in December 2013. She joined Mayo Clinic in 1995 and held a number of clinical and administrative leadership positions, including Chair of Administrative Services for the Mayo Clinic in Arizona, Chair of the Mayo Clinic Managed Care Department and Executive Director of Mayo Management Services, Inc. Ms. Weis was also previously a member of the Mayo Clinic Board of Trustees. Ms. Weis served on the Board of Directors of Obyx (formerly The Medical Memory, LLC), a Phoenix-based, private company that facilitates recording of medical conversations with doctors and distributes them to patients and families, from July 2017 to December 2021. She previously served on the Boards of Directors of Sentry Insurance Company, a mutual insurance company specializing in business insurance, from May 2015 to April 2019 and Surgalign Holdings, Inc. (formerly RTI Surgical Holdings, Inc.) (OTC: SRGAQ), a global medical technology company advancing the science of spine care, from October 2014 until May 2021. Ms. Weis holds a B.S. from Michigan State University, a Master of Management degree from Aquinas College and an honorary Doctor of Science degree from Michigan State University. She was named one of the Top 25 Women in Healthcare by Modern Healthcare magazine for 2007 and 2013.
Shirley A. Weis,自2020年7月起担任公司董事。她曾担任Weis Associates, LLC(她创立的咨询公司,专注于医疗保健管理、战略规划和领导力发展)的总裁(2014年1月以来)。此前,她曾担任Mayo Clinic(一家非营利性医疗实践和医学研究集团)的副总裁兼首席行政官(从2007年到2013年12月退休)。她于1995年加入梅奥诊所,担任多个临床和行政领导职位,包括亚利桑那州梅奥诊所行政服务主席、梅奥诊所管理护理部门主席和梅奥管理服务公司的执行董事。她还曾担任梅奥诊所董事会成员。2017年7月至2021年12月,她担任Obyx(前身为the Medical Memory, LLC)的董事会成员,这是一家总部位于Phoenix的私人公司,促进与医生的医疗对话记录并将其分发给患者和家属。2015年5月至2019年4月,她曾担任Sentry Insurance Company(一家专门从事商业保险的互助保险公司)和Surgalign Holdings, Inc.(前身为RTI Surgical Holdings, Inc.) (OTC: SRGAQ)的董事会成员,这是一家推进脊柱护理科学的全球医疗技术公司,从2014年10月至2021年5月。她持有Michigan State大学的理学士学位、阿奎那学院(Aquinas College)的管理硕士学位和Michigan State大学的荣誉理学博士学位。2007年和2013年,她被《现代医疗》杂志评为25位医疗行业女性之一。
Shirley A. Weis,has been a Director of the Company since July 2020. Ms. Weis has served as the President of Weis Associates, LLC, a consulting firm she founded focused on healthcare management, strategic planning and leadership development, since January 2014. Previously, Ms. Weis was the Vice President and Chief Administrative Officer of Mayo Clinic, a nonprofit medical practice and medical research group, from 2007 until her retirement in December 2013. She joined Mayo Clinic in 1995 and held a number of clinical and administrative leadership positions, including Chair of Administrative Services for the Mayo Clinic in Arizona, Chair of the Mayo Clinic Managed Care Department and Executive Director of Mayo Management Services, Inc. Ms. Weis was also previously a member of the Mayo Clinic Board of Trustees. Ms. Weis served on the Board of Directors of Obyx (formerly The Medical Memory, LLC), a Phoenix-based, private company that facilitates recording of medical conversations with doctors and distributes them to patients and families, from July 2017 to December 2021. She previously served on the Boards of Directors of Sentry Insurance Company, a mutual insurance company specializing in business insurance, from May 2015 to April 2019 and Surgalign Holdings, Inc. (formerly RTI Surgical Holdings, Inc.) (OTC: SRGAQ), a global medical technology company advancing the science of spine care, from October 2014 until May 2021. Ms. Weis holds a B.S. from Michigan State University, a Master of Management degree from Aquinas College and an honorary Doctor of Science degree from Michigan State University. She was named one of the Top 25 Women in Healthcare by Modern Healthcare magazine for 2007 and 2013.
Guy P. Sansone

Guy P. Sansone,他一直担任Mednax, Inc.的董事会主席(2020年7月以来)。Sansone先生自2020年2月起担任H2 Health的联合创始人、董事长和首席执行官,该公司是物理康复服务和临床医生招聘解决方案的领先区域供应商。在此之前,他担任Alvarez & Marsal董事总经理在纽约,一个金融顾问和咨询公司是以其在转变管理和性能改进工作的大型、知名企业在全球范围内,在那里他担任公司的医疗行业集团的董事长,他于2004年创立了这家公司。他也曾任职于Magellan Health, Inc.的董事会,纳斯达克:MGLN。自2019年3月以来,MGLN是一家医疗保健公司,专注于特殊人群、完整的药物福利和其他医疗保健专业领域。自2019年4月以来,Carisk Partners是一家风险转移、护理协调公司,并担任Brookdale Senior Living, Inc. (NYSE:BKD)自2020年1月起,是一家老年生活和退休社区的所有者和运营商。他曾担任Pager, Inc.(移动医疗技术公司)的顾问(2017年3月以来)。此前,他曾担任Civitas Solutions, Inc.(前纽约证券交易所代码:CIVI)的董事会成员,该公司是一家为具有智力、发育、身体或行为残疾和其他特殊需要的个人提供家庭和社区卫生和人类服务的领先国家供应商,从2009年12月到2019年3月被Celtic Intermediate Corp.和HealthPRO Heritage(一家领先的国家治疗管理和咨询服务提供商)收购,从2015年9月到2019年11月。在过去的20年里,他作为一名高管对许多公司进行了投资和咨询,专注于开发和评估旨在提升价值的战略和运营方案。他在纽约州立大学奥尔巴尼分校(the State University of New York at Albany)获得学士学位。


Guy P. Sansone,has been a Director of the Company since July 2020 and the Lead Independent Director since January 2023. Mr. Sansone previously served as Chair of the Board of Directors of the Company from July 2020 to December 2022. Mr. Sansone has served as the Co-Founder, Chairman and Chief Executive Officer of H2 Health, a leading regional provider of physical rehabilitation services and clinician staffing solutions, since February 2020. Prior to that, he served as Managing Director at Alvarez & Marsal in New York, a financial advisory and consulting firm notable for its work in turnaround management and performance improvement of a number of large, high-profile businesses across the globe, where he served as Chairman of the firm's Healthcare Industry Group, which he founded in 2004. Mr. Sansone has also served on the Boards of Directors of Longevity Health Plans (NASDAQ:CTCX), a specialized Medicare Advantage health plan, since February 2020, Ovation Healthcare LLC (formerly Qhr Health), a hospital management consultant to independent, community and rural hospitals and healthcare systems, since March 2022, ChenMed, LLC, a provider of affordable and accessible healthcare to seniors, since September 2024 and CVS Health Corporation (NYSE:CVS), a leading health solutions company, since November 2024. Previously, Mr. Sansone served on the Boards of Directors of Magellan Health, Inc. (NASDAQ:MGLN), a healthcare company focused on special populations, complete pharmacy benefits and other specialty areas of healthcare, from March 2019 to January 2022, Carisk Partners, a risk transfer, care coordination company, from April 2019 to December 2024, and Brookdale Senior Living, Inc. (NYSE:BKD), an owner and operator of senior living and retirement communities, from October 2019 to June 2024 and served as Non-Executive Chairman of Brookdale from January 2020 to June 2024. Over the past 20 years, he has invested in and consulted as an executive to numerous companies, focusing on developing and evaluating strategic and operating alternatives designed to enhance value. Mr. Sansone earned a B.S. from the State University of New York at Albany.
Guy P. Sansone,他一直担任Mednax, Inc.的董事会主席(2020年7月以来)。Sansone先生自2020年2月起担任H2 Health的联合创始人、董事长和首席执行官,该公司是物理康复服务和临床医生招聘解决方案的领先区域供应商。在此之前,他担任Alvarez & Marsal董事总经理在纽约,一个金融顾问和咨询公司是以其在转变管理和性能改进工作的大型、知名企业在全球范围内,在那里他担任公司的医疗行业集团的董事长,他于2004年创立了这家公司。他也曾任职于Magellan Health, Inc.的董事会,纳斯达克:MGLN。自2019年3月以来,MGLN是一家医疗保健公司,专注于特殊人群、完整的药物福利和其他医疗保健专业领域。自2019年4月以来,Carisk Partners是一家风险转移、护理协调公司,并担任Brookdale Senior Living, Inc. (NYSE:BKD)自2020年1月起,是一家老年生活和退休社区的所有者和运营商。他曾担任Pager, Inc.(移动医疗技术公司)的顾问(2017年3月以来)。此前,他曾担任Civitas Solutions, Inc.(前纽约证券交易所代码:CIVI)的董事会成员,该公司是一家为具有智力、发育、身体或行为残疾和其他特殊需要的个人提供家庭和社区卫生和人类服务的领先国家供应商,从2009年12月到2019年3月被Celtic Intermediate Corp.和HealthPRO Heritage(一家领先的国家治疗管理和咨询服务提供商)收购,从2015年9月到2019年11月。在过去的20年里,他作为一名高管对许多公司进行了投资和咨询,专注于开发和评估旨在提升价值的战略和运营方案。他在纽约州立大学奥尔巴尼分校(the State University of New York at Albany)获得学士学位。
Guy P. Sansone,has been a Director of the Company since July 2020 and the Lead Independent Director since January 2023. Mr. Sansone previously served as Chair of the Board of Directors of the Company from July 2020 to December 2022. Mr. Sansone has served as the Co-Founder, Chairman and Chief Executive Officer of H2 Health, a leading regional provider of physical rehabilitation services and clinician staffing solutions, since February 2020. Prior to that, he served as Managing Director at Alvarez & Marsal in New York, a financial advisory and consulting firm notable for its work in turnaround management and performance improvement of a number of large, high-profile businesses across the globe, where he served as Chairman of the firm's Healthcare Industry Group, which he founded in 2004. Mr. Sansone has also served on the Boards of Directors of Longevity Health Plans (NASDAQ:CTCX), a specialized Medicare Advantage health plan, since February 2020, Ovation Healthcare LLC (formerly Qhr Health), a hospital management consultant to independent, community and rural hospitals and healthcare systems, since March 2022, ChenMed, LLC, a provider of affordable and accessible healthcare to seniors, since September 2024 and CVS Health Corporation (NYSE:CVS), a leading health solutions company, since November 2024. Previously, Mr. Sansone served on the Boards of Directors of Magellan Health, Inc. (NASDAQ:MGLN), a healthcare company focused on special populations, complete pharmacy benefits and other specialty areas of healthcare, from March 2019 to January 2022, Carisk Partners, a risk transfer, care coordination company, from April 2019 to December 2024, and Brookdale Senior Living, Inc. (NYSE:BKD), an owner and operator of senior living and retirement communities, from October 2019 to June 2024 and served as Non-Executive Chairman of Brookdale from January 2020 to June 2024. Over the past 20 years, he has invested in and consulted as an executive to numerous companies, focusing on developing and evaluating strategic and operating alternatives designed to enhance value. Mr. Sansone earned a B.S. from the State University of New York at Albany.
Thomas A. McEachin

Thomas A. McEachin,他一直担任公司的董事(2020年7月以来)。他曾任职于Surgalign Holdings, Inc.的董事会。纳斯达克股票代码:SRGA。(前身为RTI Surgical Holdings, Inc. (NASDAQ: RTIX)),是一家推动脊柱护理科学的全球医疗技术公司。从2008年到2012年,他曾担任Covidien Surgical Solutions (Covidien plc(前纽约证券交易所代码:COV))的一个部门,Covidien Surgical Solutions(全球医疗保健产品公司和医疗设备和用品制造商)的执行职务。在Covidien Surgical Solutions任职期间,他曾担任财务副总裁(2008年至2011年),以及副总裁兼集团首席财务官(2011年至2012年)。从1997年到2008年,他曾担任United Technologies Corporation (NYSE:他曾担任普惠公司(Pratt & Whitney))的首席投资者关系官、副总裁兼财务总监,以及UTC Power的副总裁兼首席财务官。在此之前,从1986年到1997年,他在Digital Equipment Corporation(前身NYSE: DEC)担任多个行政职务,这是一家计算机系统供应商,包括计算机、软件和外围设备。1975年至1986年,他在施乐公司(NYSE: XRX)任职,这是一家销售印刷和数字文档产品和服务的全球公司,担任采购组织的总会计师。他曾担任Wadsworth Atheneum(哈特福德,CT)的受托人和官员,这是美国最古老的公共艺术机构,服务于他们的执行、财务和投资委员会。他也是康涅狄格科学中心(Connecticut Science Center)的前董事会成员和审计委员会主席。他持有New York University的学士学位和Stanford University的工商管理硕士学位。


Thomas A. McEachin,has been a Director of the Company since July 2020. Mr. McEachin has served on the Board of Federal Realty Investment Trust (NYSE:FRT), a publicly traded REIT, since October 2022. He served on the Board of Directors of Surgalign Holdings, Inc. (formerly NASDAQ:SRGA), a global medical technology company advancing the science of spine care, from December 2015 to October 2023. Previously, he held executive positions at Covidien Surgical Solutions, a division of Covidien plc (formerly NYSE:COV), a global health care products company and manufacturer of medical devices and supplies, from 2008 to 2012. During his tenure at Covidien Surgical Solutions, he served as Vice President, Finance from 2008 to 2011 and Vice President and Group Chief Financial Officer from 2011 to 2012. From 1997 to 2008, Mr. McEachin served in various finance capacities at United Technologies Corporation, a global leader in the aerospace and building industries, and its subsidiaries, including as Chief Investor Relations officer, Vice President and Controller of Pratt & Whitney, and Vice President and Chief Financial Officer of UTC Power. Prior to that, he held several executive positions with Digital Equipment Corporation (formerly NYSE:DEC), a vendor of computer systems, including computers, software, and peripherals, from 1986 to 1997. Mr. McEachin was with Xerox Corporation (n/k/a Xerox Holdings Corporation) (NYSE:XRX), a global corporation that sells print and digital document products and services, from 1975 to 1986, serving as Controller of the procurement organization. Mr. McEachin formerly served as a trustee and officer of the Wadsworth Atheneum (Hartford, CT), the oldest public art institution in the United States, serving on their executive, finance and investment committees. He also is a past board member of the Connecticut Science Center and chair of the audit committee. Mr. McEachin holds a B.S. from New York University and an MBA from Stanford University.
Thomas A. McEachin,他一直担任公司的董事(2020年7月以来)。他曾任职于Surgalign Holdings, Inc.的董事会。纳斯达克股票代码:SRGA。(前身为RTI Surgical Holdings, Inc. (NASDAQ: RTIX)),是一家推动脊柱护理科学的全球医疗技术公司。从2008年到2012年,他曾担任Covidien Surgical Solutions (Covidien plc(前纽约证券交易所代码:COV))的一个部门,Covidien Surgical Solutions(全球医疗保健产品公司和医疗设备和用品制造商)的执行职务。在Covidien Surgical Solutions任职期间,他曾担任财务副总裁(2008年至2011年),以及副总裁兼集团首席财务官(2011年至2012年)。从1997年到2008年,他曾担任United Technologies Corporation (NYSE:他曾担任普惠公司(Pratt & Whitney))的首席投资者关系官、副总裁兼财务总监,以及UTC Power的副总裁兼首席财务官。在此之前,从1986年到1997年,他在Digital Equipment Corporation(前身NYSE: DEC)担任多个行政职务,这是一家计算机系统供应商,包括计算机、软件和外围设备。1975年至1986年,他在施乐公司(NYSE: XRX)任职,这是一家销售印刷和数字文档产品和服务的全球公司,担任采购组织的总会计师。他曾担任Wadsworth Atheneum(哈特福德,CT)的受托人和官员,这是美国最古老的公共艺术机构,服务于他们的执行、财务和投资委员会。他也是康涅狄格科学中心(Connecticut Science Center)的前董事会成员和审计委员会主席。他持有New York University的学士学位和Stanford University的工商管理硕士学位。
Thomas A. McEachin,has been a Director of the Company since July 2020. Mr. McEachin has served on the Board of Federal Realty Investment Trust (NYSE:FRT), a publicly traded REIT, since October 2022. He served on the Board of Directors of Surgalign Holdings, Inc. (formerly NASDAQ:SRGA), a global medical technology company advancing the science of spine care, from December 2015 to October 2023. Previously, he held executive positions at Covidien Surgical Solutions, a division of Covidien plc (formerly NYSE:COV), a global health care products company and manufacturer of medical devices and supplies, from 2008 to 2012. During his tenure at Covidien Surgical Solutions, he served as Vice President, Finance from 2008 to 2011 and Vice President and Group Chief Financial Officer from 2011 to 2012. From 1997 to 2008, Mr. McEachin served in various finance capacities at United Technologies Corporation, a global leader in the aerospace and building industries, and its subsidiaries, including as Chief Investor Relations officer, Vice President and Controller of Pratt & Whitney, and Vice President and Chief Financial Officer of UTC Power. Prior to that, he held several executive positions with Digital Equipment Corporation (formerly NYSE:DEC), a vendor of computer systems, including computers, software, and peripherals, from 1986 to 1997. Mr. McEachin was with Xerox Corporation (n/k/a Xerox Holdings Corporation) (NYSE:XRX), a global corporation that sells print and digital document products and services, from 1975 to 1986, serving as Controller of the procurement organization. Mr. McEachin formerly served as a trustee and officer of the Wadsworth Atheneum (Hartford, CT), the oldest public art institution in the United States, serving on their executive, finance and investment committees. He also is a past board member of the Connecticut Science Center and chair of the audit committee. Mr. McEachin holds a B.S. from New York University and an MBA from Stanford University.
John M. Starcher, Jr.

John M. Starcher, Jr.,他一直担任公司的董事(2020年7月以来)。Starcher先生是总裁和首席执行官Bon Secours Mercy Health,一个非盈利天主教卫生系统,拥有并经营着48急症护理医院、1000多个网站的护理服务超过1000万例,有60000多名员工在7个州和两个国家,自2018年9月起担任该职位。此前,他曾担任Mercy Health的首席执行官兼总裁(从2016年4月到2018年8月),在那里他负责俄亥俄州和肯塔基州所有23家Mercy Health医院和临床综合网络的系统战略和运营的开发。2015年1月至2016年4月,Starcher先生担任Mercy Health的运营执行副总裁和首席执行官。从2013年8月到2014年3月,他担任健康管理协会(Health Management Associates Inc.,前身NYSE:HMA)的临时总裁兼首席执行官,该公司是横跨15个州的71家医院的综合急性护理交付系统,在那里他指导HMA通过其成功出售给社区卫生系统。在此之前,Starcher先生从2012年2月到2013年8月担任HMA的东部集团总裁。在加入HMA之前,他曾担任Mercy Health四个部门中的三个的首席执行官,监管20多家急性护理医院、5个长期护理设施、6个家庭健康机构和几十个附属临床实践,净收入超过30亿美元。在此之前,他曾担任宾夕法尼亚州东北部地区的首席执行官、Human Resources的高级副总裁和Catholic Health Partners的企业助理总法律顾问。Starcher先生于1993年在俄亥俄州医学院(Medical College of Ohio)的人力资源部门开始他的职业生涯,担任劳动关系主任,直到1999年加入Catholic Health Partners。Starcher先生是Bon Secours Mercy Health、Ensemble Health Partners、the Innovation Institute, Lirio, LLC和American Pain Consortium, LLC的董事。他也是HealthQuest Capital的顾问委员会成员。他持有Bowling Green State大学的工商管理学士学位和Toledo大学的法学博士学位。他获得俄亥俄州(目前不活跃)的法律执业许可,并积极担任多个行业的20多个董事会的董事,包括银行、保险、急性和亚急性医疗保健、专业护理和医生执业组织。


John M. Starcher, Jr.,has been a Director of the Company since July 2020. Mr. Starcher is the President and Chief Executive Officer of Bon Secours Mercy Health, a not-for-profit Catholic health system that owns and operates 50 acute care hospitals, over 1,000 sites of care serving more than 10 million patients and has more than 60,000 employees across seven states and two countries, where he has served since September 2018. Prior to this, he served as Chief Executive Officer and President of Mercy Health from April 2016 to August 2018, where he oversaw the development of system strategies and operations for all 23 Mercy Health hospitals and the clinically integrated network across Ohio and Kentucky. Before being promoted to Chief Executive Officer at Mercy Health, Mr. Starcher served as an Executive Vice President of Operations and Chief Executive Officer of the Cincinnati Market at Mercy Health from January 2015 to April 2016. From August 2013 to March 2014, Mr. Starcher served as the Interim President and Chief Executive Officer of Health Management Associates Inc. (formerly NYSE:HMA) ("HMA"), an integrated acute care delivery system with 71 hospitals across 15 states, where he guided HMA through its successful sale to Community Health Systems. Prior to that, Mr. Starcher served as President of HMA's Eastern Group from February 2012 to August 2013. Before joining HMA, Mr. Starcher served as the Chief Executive Officer of three of Mercy Health's four divisions — overseeing more than 20 acute care hospitals, five long term care facilities, six home health agencies, and dozens of affiliated clinical practices with more than $3 billion in net revenue. Prior to that, he served as the Chief Executive Officer of the Northeastern Pennsylvania Region, the senior vice president of Human Resources and corporate associate general counsel at Catholic Health Partners. Mr. Starcher started his career in 1993 in Human Resources at the Medical College of Ohio as the Director of Labor Relations where he worked until he joined Catholic Health Partners in 1999. Mr. Starcher serves as a Director on the Boards of Bon Secours Mercy Health, Ensemble Health Partners (NASDAQ: ENSB) and American Pain Consortium, LLC. He also serves on the Advisory Board of HealthQuest Capital. Mr. Starcher holds a Bachelor of Science in Business Administration degree from Bowling Green State University and J.D. from the University of Toledo. He is licensed to practice law in the State of Ohio (currently inactive) and has actively served as a Director on more than 20 boards in varied industries, including banking, insurance, acute and sub-acute healthcare, specialty care, and physician practice organizations.
John M. Starcher, Jr.,他一直担任公司的董事(2020年7月以来)。Starcher先生是总裁和首席执行官Bon Secours Mercy Health,一个非盈利天主教卫生系统,拥有并经营着48急症护理医院、1000多个网站的护理服务超过1000万例,有60000多名员工在7个州和两个国家,自2018年9月起担任该职位。此前,他曾担任Mercy Health的首席执行官兼总裁(从2016年4月到2018年8月),在那里他负责俄亥俄州和肯塔基州所有23家Mercy Health医院和临床综合网络的系统战略和运营的开发。2015年1月至2016年4月,Starcher先生担任Mercy Health的运营执行副总裁和首席执行官。从2013年8月到2014年3月,他担任健康管理协会(Health Management Associates Inc.,前身NYSE:HMA)的临时总裁兼首席执行官,该公司是横跨15个州的71家医院的综合急性护理交付系统,在那里他指导HMA通过其成功出售给社区卫生系统。在此之前,Starcher先生从2012年2月到2013年8月担任HMA的东部集团总裁。在加入HMA之前,他曾担任Mercy Health四个部门中的三个的首席执行官,监管20多家急性护理医院、5个长期护理设施、6个家庭健康机构和几十个附属临床实践,净收入超过30亿美元。在此之前,他曾担任宾夕法尼亚州东北部地区的首席执行官、Human Resources的高级副总裁和Catholic Health Partners的企业助理总法律顾问。Starcher先生于1993年在俄亥俄州医学院(Medical College of Ohio)的人力资源部门开始他的职业生涯,担任劳动关系主任,直到1999年加入Catholic Health Partners。Starcher先生是Bon Secours Mercy Health、Ensemble Health Partners、the Innovation Institute, Lirio, LLC和American Pain Consortium, LLC的董事。他也是HealthQuest Capital的顾问委员会成员。他持有Bowling Green State大学的工商管理学士学位和Toledo大学的法学博士学位。他获得俄亥俄州(目前不活跃)的法律执业许可,并积极担任多个行业的20多个董事会的董事,包括银行、保险、急性和亚急性医疗保健、专业护理和医生执业组织。
John M. Starcher, Jr.,has been a Director of the Company since July 2020. Mr. Starcher is the President and Chief Executive Officer of Bon Secours Mercy Health, a not-for-profit Catholic health system that owns and operates 50 acute care hospitals, over 1,000 sites of care serving more than 10 million patients and has more than 60,000 employees across seven states and two countries, where he has served since September 2018. Prior to this, he served as Chief Executive Officer and President of Mercy Health from April 2016 to August 2018, where he oversaw the development of system strategies and operations for all 23 Mercy Health hospitals and the clinically integrated network across Ohio and Kentucky. Before being promoted to Chief Executive Officer at Mercy Health, Mr. Starcher served as an Executive Vice President of Operations and Chief Executive Officer of the Cincinnati Market at Mercy Health from January 2015 to April 2016. From August 2013 to March 2014, Mr. Starcher served as the Interim President and Chief Executive Officer of Health Management Associates Inc. (formerly NYSE:HMA) ("HMA"), an integrated acute care delivery system with 71 hospitals across 15 states, where he guided HMA through its successful sale to Community Health Systems. Prior to that, Mr. Starcher served as President of HMA's Eastern Group from February 2012 to August 2013. Before joining HMA, Mr. Starcher served as the Chief Executive Officer of three of Mercy Health's four divisions — overseeing more than 20 acute care hospitals, five long term care facilities, six home health agencies, and dozens of affiliated clinical practices with more than $3 billion in net revenue. Prior to that, he served as the Chief Executive Officer of the Northeastern Pennsylvania Region, the senior vice president of Human Resources and corporate associate general counsel at Catholic Health Partners. Mr. Starcher started his career in 1993 in Human Resources at the Medical College of Ohio as the Director of Labor Relations where he worked until he joined Catholic Health Partners in 1999. Mr. Starcher serves as a Director on the Boards of Bon Secours Mercy Health, Ensemble Health Partners (NASDAQ: ENSB) and American Pain Consortium, LLC. He also serves on the Advisory Board of HealthQuest Capital. Mr. Starcher holds a Bachelor of Science in Business Administration degree from Bowling Green State University and J.D. from the University of Toledo. He is licensed to practice law in the State of Ohio (currently inactive) and has actively served as a Director on more than 20 boards in varied industries, including banking, insurance, acute and sub-acute healthcare, specialty care, and physician practice organizations.
Mark S. Ordan

Mark S. Ordan是The Carlyle Group Inc.董事会成员。Ordan先生当选为The Carlyle Group Inc.董事会成员,自2022年4月1日起生效,并担任薪酬委员会成员。Ordan先生于2023年1月被任命为Pediatrix Medical Group执行主席,并曾于2020年7月至2022年12月担任Pediatrix Medical Group首席执行官。在加入Pediatrix Medical Group之前,Ordan先生在担任Washington Prime Group的创始首席执行官之后,创立并担任Quality Care Properties的首席执行官。Ordan曾在Sunrise Senior Living、The Mills Corporation、Balducci's等公司担任过多个首席执行官职务,还曾是Fresh Fields Markets的创始人和首席执行官,后来他与Whole Foods Markets合并。Ordan先生是Pediatrix Medical Group执行主席、the U.S. Chamber of Commerce董事会主席和The Carlyle Group董事会成员。Ordan在Vassar College获得了学士学位,在哈佛商学院获得了MBA学位。他是Vassar College和Holton-Arms School的董事会成员。


Mark S. Ordan,has been a Director of the Company since July 2020 and was appointed to serve as Chair of Board of Directors and Chief Executive Officer in January 2025. He previously served as Chief Executive Officer from July 2020 to December 2022. In addition, Mr. Ordan served as Executive Chair of Board of Directors from January 2023 to June 2023 and from October 2024 to January 2025 and as Chair of Board from July 2023 to October 2024. Mr. Ordan previously served in various capacities for Quality Care Properties, Inc. (NYSE:QCP), Washington Prime Group Inc. (NYSE:WPG), Sunrise Senior Living, Inc. (formerly NYSE:SZR) and The Mills Corporation (NYSE:MLS), including at various times serving as the Chief Executive Officer and member of the Board of Directors of each, and was founder and Chief Executive Officer of Fresh Fields Markets. Mr. Ordan has served on the Board of Directors of The Carlyle Group (NASDAQ:CG) since April 1, 2022 and currently serves as its Lead Independent Director. Previously, Mr. Ordan served on the Board of Trustees of Federal Realty Investment Trust (NYSE:FRT) from February 2019 to September 2022, where he also previously served from 1996 to 2006, including as Chairman from 2001 to 2006. Mr. Ordan also previously served on the Board of Directors of VEREIT, Inc. (NYSE:VER) and Harris Teeter Supermarkets, Inc. (NYSE:HTSI). Mr. Ordan currently serves as Chairman of the U.S. Chamber of Commerce and as President of the Board of the Holton-Arms School. Mr. Ordan served for 20 years on the Board of Vassar College. Mr. Ordan received a B.A. from Vassar College and an MBA from Harvard Business School.
Mark S. Ordan是The Carlyle Group Inc.董事会成员。Ordan先生当选为The Carlyle Group Inc.董事会成员,自2022年4月1日起生效,并担任薪酬委员会成员。Ordan先生于2023年1月被任命为Pediatrix Medical Group执行主席,并曾于2020年7月至2022年12月担任Pediatrix Medical Group首席执行官。在加入Pediatrix Medical Group之前,Ordan先生在担任Washington Prime Group的创始首席执行官之后,创立并担任Quality Care Properties的首席执行官。Ordan曾在Sunrise Senior Living、The Mills Corporation、Balducci's等公司担任过多个首席执行官职务,还曾是Fresh Fields Markets的创始人和首席执行官,后来他与Whole Foods Markets合并。Ordan先生是Pediatrix Medical Group执行主席、the U.S. Chamber of Commerce董事会主席和The Carlyle Group董事会成员。Ordan在Vassar College获得了学士学位,在哈佛商学院获得了MBA学位。他是Vassar College和Holton-Arms School的董事会成员。
Mark S. Ordan,has been a Director of the Company since July 2020 and was appointed to serve as Chair of Board of Directors and Chief Executive Officer in January 2025. He previously served as Chief Executive Officer from July 2020 to December 2022. In addition, Mr. Ordan served as Executive Chair of Board of Directors from January 2023 to June 2023 and from October 2024 to January 2025 and as Chair of Board from July 2023 to October 2024. Mr. Ordan previously served in various capacities for Quality Care Properties, Inc. (NYSE:QCP), Washington Prime Group Inc. (NYSE:WPG), Sunrise Senior Living, Inc. (formerly NYSE:SZR) and The Mills Corporation (NYSE:MLS), including at various times serving as the Chief Executive Officer and member of the Board of Directors of each, and was founder and Chief Executive Officer of Fresh Fields Markets. Mr. Ordan has served on the Board of Directors of The Carlyle Group (NASDAQ:CG) since April 1, 2022 and currently serves as its Lead Independent Director. Previously, Mr. Ordan served on the Board of Trustees of Federal Realty Investment Trust (NYSE:FRT) from February 2019 to September 2022, where he also previously served from 1996 to 2006, including as Chairman from 2001 to 2006. Mr. Ordan also previously served on the Board of Directors of VEREIT, Inc. (NYSE:VER) and Harris Teeter Supermarkets, Inc. (NYSE:HTSI). Mr. Ordan currently serves as Chairman of the U.S. Chamber of Commerce and as President of the Board of the Holton-Arms School. Mr. Ordan served for 20 years on the Board of Vassar College. Mr. Ordan received a B.A. from Vassar College and an MBA from Harvard Business School.
Laura Linynsky

Laura Linynsky,自2022年5月起担任公司董事。Linynsky女士自2018年8月起担任专注于医疗保健管理的顾问,为初创组织和扩张组织提供运营、质量护理、就业、ESG和监管指导。Linynsky女士此前曾于2016年至2018年担任Quality Care Properties(NYSE:QCP)的高级副总裁,该公司是一家房地产公司,拥有超过300处急性后/熟练护理和辅助生活物业。在那里,她负责社区的运营和财务监督,并且是全面重组与HCR ManorCare及其唯一房东关系以将两者结合的执行团队的一员。她曾担任HCR ManorCare的临时首席财务官,直到该公司于2018年7月被出售。在此之前,2010年至2013年,她曾担任旭日养生医疗(前纽约证券交易所代码:SZ)(“Sunrise”)的首席运营官和运营主管,负责监督美国、加拿大和英国的业务,并且是领导公司运营和财务扭亏为盈的高级团队的一员。在领导Sunrise运营之前,Linynsky女士曾担任房地产和资产管理副总裁,并于2002年至2010年担任收购总监。在加入Sunrise之前,Linynsky女士曾在万豪国际酒店(NASDAQ:MAR)、Nextel Communications(前NYSE:FON)和Cogent通讯(NASDAQ:CCOI)等公司担任过各种财务、税务和业务发展职务。她是Argentum和国家老年人住房投资中心的前任董事会成员,这两个组织都是非营利组织。Linynsky女士拥有超过20年的公司财务、会计和税务经验,在老年住房医疗保健行业拥有超过10年的经验。Linynsky女士获得了哥伦比亚南卡罗来纳大学的学士学位。


Laura Linynsky,has been a Director of the Company since May 2022. Ms. Linynsky has served as a consultant focused on healthcare management, providing operational, quality care, employment, ESG and regulatory guidance for both start up and expanding organizations since August 2018. Ms. Linynsky previously served as Senior Vice President of Quality Care Properties (NYSE:QCP), a real estate company that owned over 300 post-acute/skilled nursing and assisted living properties, from 2016 to 2018, where she was responsible for operational and financial oversight of the communities and was part of the executive team that fully restructured the relationship with HCR ManorCare and its sole landlord to combine the two. She served as interim Chief Financial Officer for HCR ManorCare until the company was sold in July 2018. Prior to this, from 2010 to 2013, she served as Chief Operating Officer and head of Operations for Sunrise Senior Living, Inc. (formerly NYSE:SZR) ("Sunrise") where she oversaw operations in the United States, Canada and the UK and was part of the senior team who led the company's operating and financial turnaround. Before leading Sunrise operations, Ms. Linynsky served as Vice President, Real Estate and Asset Management and was Director of Acquisitions from 2002 to 2010. Prior to Sunrise, Ms. Linynsky served in various finance, tax and business development roles at, among other companies, Marriott International (NASDAQ:MAR), Nextel Communications (formerly NYSE:FON) and Cogent Communications (NASDAQ:CCOI). She is a past board member of Argentum and the National Investment Center for Seniors Housing, both non-profit organizations. Ms. Linynsky has over 20-plus years of corporate finance, accounting, and tax experience with over 10 years' experience in the senior housing healthcare industry. Ms. Linynsky earned a B.S. from the University of South Carolina, Columbia.
Laura Linynsky,自2022年5月起担任公司董事。Linynsky女士自2018年8月起担任专注于医疗保健管理的顾问,为初创组织和扩张组织提供运营、质量护理、就业、ESG和监管指导。Linynsky女士此前曾于2016年至2018年担任Quality Care Properties(NYSE:QCP)的高级副总裁,该公司是一家房地产公司,拥有超过300处急性后/熟练护理和辅助生活物业。在那里,她负责社区的运营和财务监督,并且是全面重组与HCR ManorCare及其唯一房东关系以将两者结合的执行团队的一员。她曾担任HCR ManorCare的临时首席财务官,直到该公司于2018年7月被出售。在此之前,2010年至2013年,她曾担任旭日养生医疗(前纽约证券交易所代码:SZ)(“Sunrise”)的首席运营官和运营主管,负责监督美国、加拿大和英国的业务,并且是领导公司运营和财务扭亏为盈的高级团队的一员。在领导Sunrise运营之前,Linynsky女士曾担任房地产和资产管理副总裁,并于2002年至2010年担任收购总监。在加入Sunrise之前,Linynsky女士曾在万豪国际酒店(NASDAQ:MAR)、Nextel Communications(前NYSE:FON)和Cogent通讯(NASDAQ:CCOI)等公司担任过各种财务、税务和业务发展职务。她是Argentum和国家老年人住房投资中心的前任董事会成员,这两个组织都是非营利组织。Linynsky女士拥有超过20年的公司财务、会计和税务经验,在老年住房医疗保健行业拥有超过10年的经验。Linynsky女士获得了哥伦比亚南卡罗来纳大学的学士学位。
Laura Linynsky,has been a Director of the Company since May 2022. Ms. Linynsky has served as a consultant focused on healthcare management, providing operational, quality care, employment, ESG and regulatory guidance for both start up and expanding organizations since August 2018. Ms. Linynsky previously served as Senior Vice President of Quality Care Properties (NYSE:QCP), a real estate company that owned over 300 post-acute/skilled nursing and assisted living properties, from 2016 to 2018, where she was responsible for operational and financial oversight of the communities and was part of the executive team that fully restructured the relationship with HCR ManorCare and its sole landlord to combine the two. She served as interim Chief Financial Officer for HCR ManorCare until the company was sold in July 2018. Prior to this, from 2010 to 2013, she served as Chief Operating Officer and head of Operations for Sunrise Senior Living, Inc. (formerly NYSE:SZR) ("Sunrise") where she oversaw operations in the United States, Canada and the UK and was part of the senior team who led the company's operating and financial turnaround. Before leading Sunrise operations, Ms. Linynsky served as Vice President, Real Estate and Asset Management and was Director of Acquisitions from 2002 to 2010. Prior to Sunrise, Ms. Linynsky served in various finance, tax and business development roles at, among other companies, Marriott International (NASDAQ:MAR), Nextel Communications (formerly NYSE:FON) and Cogent Communications (NASDAQ:CCOI). She is a past board member of Argentum and the National Investment Center for Seniors Housing, both non-profit organizations. Ms. Linynsky has over 20-plus years of corporate finance, accounting, and tax experience with over 10 years' experience in the senior housing healthcare industry. Ms. Linynsky earned a B.S. from the University of South Carolina, Columbia.
Sylvia J. Young

Sylvia J. Young,自2023年5月起担任公司董事。Young Mrs. Young目前是Young Consulting Advisors,LLC的所有者,作为一名敬业的医院管理资深人士,她为医疗保健咨询和高管培训带来了超过35年的经验。自2024年8月起,她担任私营医疗设备公司Cerebell,Inc.的顾问。Young女士最近担任HCA大陆分部的总裁兼首席执行官,该分部是一个多州区域医疗保健系统,隶属于美国医院公司(“HCA”)。在被任命为总部位于丹佛的部门总部之前,Young女士曾担任HCA Sunrise健康系统的总裁,该系统包括Sunrise医院和医疗中心、Sunrise儿童医院、Mountain View医院和Southern Hills医院,以及位于内华达州拉斯维加斯的四个门诊手术中心。Young女士于2023年3月从HCA退休。Young女士在Lincoln Educational Services Corporation的董事会、薪酬与人才委员会以及丹佛表演艺术中心的董事会担任独立董事,并担任审计委员会主席。Young女士拥有伯明翰阿拉巴马大学健康管理理学硕士学位和伯明翰桑福德大学公共管理文学学士学位。2022年,Mrs. Young被《Modern Healthcare》杂志评为“2022年度医疗保健领域最值得关注的女性”之一。


Sylvia J. Young,has been a Director of the Company since May 2023. She has served as a consultant to Cerebell, Inc., a privately held medical device company, since August 2024. Mrs. Young most recently served as President and Chief Executive Officer of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America ("HCA"). Prior to her appointment to the Denver-based Division headquarters, Mrs. Young served as President of HCA's Sunrise Health System, including Sunrise Hospital and Medical Center, Sunrise Children's Hospital, Mountain View Hospital and Southern Hills Hospital, as well as four ambulatory surgery centers in Las Vegas, NV. Mrs. Young retired from HCA in March 2023. Mrs. Young serves as an Independent Director on the Board of Directors and Compensation and Talent Committee of Lincoln Educational Services Corporation and on the Board of Directors of the Denver Center for Performing Arts where she serves as Chair of the Audit Committee. Mrs. Young holds a Master of Science degree in Health Administration from the University of Alabama, Birmingham and a Bachelor of Arts in Public Administration degree from Samford University in Birmingham. In 2022, Mrs. Young was named as one of the "2022 Top Women to Watch in Healthcare" by Modern Healthcare Magazine.
Sylvia J. Young,自2023年5月起担任公司董事。Young Mrs. Young目前是Young Consulting Advisors,LLC的所有者,作为一名敬业的医院管理资深人士,她为医疗保健咨询和高管培训带来了超过35年的经验。自2024年8月起,她担任私营医疗设备公司Cerebell,Inc.的顾问。Young女士最近担任HCA大陆分部的总裁兼首席执行官,该分部是一个多州区域医疗保健系统,隶属于美国医院公司(“HCA”)。在被任命为总部位于丹佛的部门总部之前,Young女士曾担任HCA Sunrise健康系统的总裁,该系统包括Sunrise医院和医疗中心、Sunrise儿童医院、Mountain View医院和Southern Hills医院,以及位于内华达州拉斯维加斯的四个门诊手术中心。Young女士于2023年3月从HCA退休。Young女士在Lincoln Educational Services Corporation的董事会、薪酬与人才委员会以及丹佛表演艺术中心的董事会担任独立董事,并担任审计委员会主席。Young女士拥有伯明翰阿拉巴马大学健康管理理学硕士学位和伯明翰桑福德大学公共管理文学学士学位。2022年,Mrs. Young被《Modern Healthcare》杂志评为“2022年度医疗保健领域最值得关注的女性”之一。
Sylvia J. Young,has been a Director of the Company since May 2023. She has served as a consultant to Cerebell, Inc., a privately held medical device company, since August 2024. Mrs. Young most recently served as President and Chief Executive Officer of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America ("HCA"). Prior to her appointment to the Denver-based Division headquarters, Mrs. Young served as President of HCA's Sunrise Health System, including Sunrise Hospital and Medical Center, Sunrise Children's Hospital, Mountain View Hospital and Southern Hills Hospital, as well as four ambulatory surgery centers in Las Vegas, NV. Mrs. Young retired from HCA in March 2023. Mrs. Young serves as an Independent Director on the Board of Directors and Compensation and Talent Committee of Lincoln Educational Services Corporation and on the Board of Directors of the Denver Center for Performing Arts where she serves as Chair of the Audit Committee. Mrs. Young holds a Master of Science degree in Health Administration from the University of Alabama, Birmingham and a Bachelor of Arts in Public Administration degree from Samford University in Birmingham. In 2022, Mrs. Young was named as one of the "2022 Top Women to Watch in Healthcare" by Modern Healthcare Magazine.
Kurt Newman

Kurt Newman是一名外科医生,也是国家公认的儿科医疗保健领导者,也是医疗保健的长期高管,曾担任国家儿童医院的总裁兼首席执行官长达12年,此前他在那里担任了超过25年的儿科外科医生。纽曼博士培养了以患者为中心的护理文化,并倡导了研究、运营和临床护理方面的创新文化。纽曼博士是扩大儿童心理健康机会的坚定倡导者,并领导了两个关于这个问题的全国性论坛。他著有畅销书《治愈儿童:一位来自儿科医学前沿的外科医生的故事》。纽曼博士被《华盛顿商业日报》评为2021年“年度CEO”,并于2023年入选华盛顿商业Hall of Fame。


Kurt Newman,a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric surgeon. Dr. Newman fostered a culture of patient-centered care and championed a culture of innovation in research, operations and clinical care. Dr. Newman is a strong advocate for expanding mental health access for children and has led two national forums on this issue. He is the author of a best-selling book, "Healing Children: a Surgeon's Stories from the Frontiers of Pediatric Medicine." Dr. Newman was recognized as "CEO of the Year" by the Washington Business Journal in 2021 and inducted into the Washington Business Hall of Fame in 2023.
Kurt Newman是一名外科医生,也是国家公认的儿科医疗保健领导者,也是医疗保健的长期高管,曾担任国家儿童医院的总裁兼首席执行官长达12年,此前他在那里担任了超过25年的儿科外科医生。纽曼博士培养了以患者为中心的护理文化,并倡导了研究、运营和临床护理方面的创新文化。纽曼博士是扩大儿童心理健康机会的坚定倡导者,并领导了两个关于这个问题的全国性论坛。他著有畅销书《治愈儿童:一位来自儿科医学前沿的外科医生的故事》。纽曼博士被《华盛顿商业日报》评为2021年“年度CEO”,并于2023年入选华盛顿商业Hall of Fame。
Kurt Newman,a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric surgeon. Dr. Newman fostered a culture of patient-centered care and championed a culture of innovation in research, operations and clinical care. Dr. Newman is a strong advocate for expanding mental health access for children and has led two national forums on this issue. He is the author of a best-selling book, "Healing Children: a Surgeon's Stories from the Frontiers of Pediatric Medicine." Dr. Newman was recognized as "CEO of the Year" by the Washington Business Journal in 2021 and inducted into the Washington Business Hall of Fame in 2023.
Michael A. Rucker

Michael A. Rucker是执行副总裁兼首席运营官,他从2009年开始担任该职位。加入SCA前,从1995年到2008年,Rucker先生担任达维塔(DaVita)与其前身公司的多个职位,包括最后担任运营部的部门副总裁。Rucker先生还担任Houlihan, Lokey, Howard & Zukin Inc.的医疗保健事业部的律师,并作为注册会计师从事公共会计。Rucker先生在Pennsylvania大学沃顿商学院获得工商管理硕士学位,并在迈阿密大学获得学士学位。


Michael A. Rucker,has been a Director of the Company since May 2019. Mr. Rucker has served as Chief Executive Officer since 2017 and as a member of the Board of Directors since 2016 of Ivy Rehab Network, Inc., one of the largest networks of physical therapy clinics in the United States. Prior to joining Ivy Rehab, Mr. Rucker served from 2010 to 2017 as Executive Vice President and Chief Operating Officer of Surgical Care Affiliates, Inc. (formerly NASDAQ:SCAI), at the time a publicly traded operator of one of the nation's largest networks of surgical facilities, until its acquisition by United Health Group. Mr. Rucker has also held executive roles in various healthcare companies, including DaVita, Inc. (NYSE:DVA), where he served as Division Vice President from 2005 to 2008 after DaVita acquired Gambro Healthcare, where Mr. Rucker had served in various general management and business development capacities since 1997. Mr. Rucker, a former certified public accountant, holds a B.S. from Miami University and an MBA from the University of Pennsylvania's Wharton School of Business.
Michael A. Rucker是执行副总裁兼首席运营官,他从2009年开始担任该职位。加入SCA前,从1995年到2008年,Rucker先生担任达维塔(DaVita)与其前身公司的多个职位,包括最后担任运营部的部门副总裁。Rucker先生还担任Houlihan, Lokey, Howard & Zukin Inc.的医疗保健事业部的律师,并作为注册会计师从事公共会计。Rucker先生在Pennsylvania大学沃顿商学院获得工商管理硕士学位,并在迈阿密大学获得学士学位。
Michael A. Rucker,has been a Director of the Company since May 2019. Mr. Rucker has served as Chief Executive Officer since 2017 and as a member of the Board of Directors since 2016 of Ivy Rehab Network, Inc., one of the largest networks of physical therapy clinics in the United States. Prior to joining Ivy Rehab, Mr. Rucker served from 2010 to 2017 as Executive Vice President and Chief Operating Officer of Surgical Care Affiliates, Inc. (formerly NASDAQ:SCAI), at the time a publicly traded operator of one of the nation's largest networks of surgical facilities, until its acquisition by United Health Group. Mr. Rucker has also held executive roles in various healthcare companies, including DaVita, Inc. (NYSE:DVA), where he served as Division Vice President from 2005 to 2008 after DaVita acquired Gambro Healthcare, where Mr. Rucker had served in various general management and business development capacities since 1997. Mr. Rucker, a former certified public accountant, holds a B.S. from Miami University and an MBA from the University of Pennsylvania's Wharton School of Business.

高管简历

中英对照 |  中文 |  英文
Mark S. Ordan

Mark S. Ordan是The Carlyle Group Inc.董事会成员。Ordan先生当选为The Carlyle Group Inc.董事会成员,自2022年4月1日起生效,并担任薪酬委员会成员。Ordan先生于2023年1月被任命为Pediatrix Medical Group执行主席,并曾于2020年7月至2022年12月担任Pediatrix Medical Group首席执行官。在加入Pediatrix Medical Group之前,Ordan先生在担任Washington Prime Group的创始首席执行官之后,创立并担任Quality Care Properties的首席执行官。Ordan曾在Sunrise Senior Living、The Mills Corporation、Balducci's等公司担任过多个首席执行官职务,还曾是Fresh Fields Markets的创始人和首席执行官,后来他与Whole Foods Markets合并。Ordan先生是Pediatrix Medical Group执行主席、the U.S. Chamber of Commerce董事会主席和The Carlyle Group董事会成员。Ordan在Vassar College获得了学士学位,在哈佛商学院获得了MBA学位。他是Vassar College和Holton-Arms School的董事会成员。


Mark S. Ordan,has been a Director of the Company since July 2020 and was appointed to serve as Chair of Board of Directors and Chief Executive Officer in January 2025. He previously served as Chief Executive Officer from July 2020 to December 2022. In addition, Mr. Ordan served as Executive Chair of Board of Directors from January 2023 to June 2023 and from October 2024 to January 2025 and as Chair of Board from July 2023 to October 2024. Mr. Ordan previously served in various capacities for Quality Care Properties, Inc. (NYSE:QCP), Washington Prime Group Inc. (NYSE:WPG), Sunrise Senior Living, Inc. (formerly NYSE:SZR) and The Mills Corporation (NYSE:MLS), including at various times serving as the Chief Executive Officer and member of the Board of Directors of each, and was founder and Chief Executive Officer of Fresh Fields Markets. Mr. Ordan has served on the Board of Directors of The Carlyle Group (NASDAQ:CG) since April 1, 2022 and currently serves as its Lead Independent Director. Previously, Mr. Ordan served on the Board of Trustees of Federal Realty Investment Trust (NYSE:FRT) from February 2019 to September 2022, where he also previously served from 1996 to 2006, including as Chairman from 2001 to 2006. Mr. Ordan also previously served on the Board of Directors of VEREIT, Inc. (NYSE:VER) and Harris Teeter Supermarkets, Inc. (NYSE:HTSI). Mr. Ordan currently serves as Chairman of the U.S. Chamber of Commerce and as President of the Board of the Holton-Arms School. Mr. Ordan served for 20 years on the Board of Vassar College. Mr. Ordan received a B.A. from Vassar College and an MBA from Harvard Business School.
Mark S. Ordan是The Carlyle Group Inc.董事会成员。Ordan先生当选为The Carlyle Group Inc.董事会成员,自2022年4月1日起生效,并担任薪酬委员会成员。Ordan先生于2023年1月被任命为Pediatrix Medical Group执行主席,并曾于2020年7月至2022年12月担任Pediatrix Medical Group首席执行官。在加入Pediatrix Medical Group之前,Ordan先生在担任Washington Prime Group的创始首席执行官之后,创立并担任Quality Care Properties的首席执行官。Ordan曾在Sunrise Senior Living、The Mills Corporation、Balducci's等公司担任过多个首席执行官职务,还曾是Fresh Fields Markets的创始人和首席执行官,后来他与Whole Foods Markets合并。Ordan先生是Pediatrix Medical Group执行主席、the U.S. Chamber of Commerce董事会主席和The Carlyle Group董事会成员。Ordan在Vassar College获得了学士学位,在哈佛商学院获得了MBA学位。他是Vassar College和Holton-Arms School的董事会成员。
Mark S. Ordan,has been a Director of the Company since July 2020 and was appointed to serve as Chair of Board of Directors and Chief Executive Officer in January 2025. He previously served as Chief Executive Officer from July 2020 to December 2022. In addition, Mr. Ordan served as Executive Chair of Board of Directors from January 2023 to June 2023 and from October 2024 to January 2025 and as Chair of Board from July 2023 to October 2024. Mr. Ordan previously served in various capacities for Quality Care Properties, Inc. (NYSE:QCP), Washington Prime Group Inc. (NYSE:WPG), Sunrise Senior Living, Inc. (formerly NYSE:SZR) and The Mills Corporation (NYSE:MLS), including at various times serving as the Chief Executive Officer and member of the Board of Directors of each, and was founder and Chief Executive Officer of Fresh Fields Markets. Mr. Ordan has served on the Board of Directors of The Carlyle Group (NASDAQ:CG) since April 1, 2022 and currently serves as its Lead Independent Director. Previously, Mr. Ordan served on the Board of Trustees of Federal Realty Investment Trust (NYSE:FRT) from February 2019 to September 2022, where he also previously served from 1996 to 2006, including as Chairman from 2001 to 2006. Mr. Ordan also previously served on the Board of Directors of VEREIT, Inc. (NYSE:VER) and Harris Teeter Supermarkets, Inc. (NYSE:HTSI). Mr. Ordan currently serves as Chairman of the U.S. Chamber of Commerce and as President of the Board of the Holton-Arms School. Mr. Ordan served for 20 years on the Board of Vassar College. Mr. Ordan received a B.A. from Vassar College and an MBA from Harvard Business School.
Kasandra H. Rossi

Kasandra H. Rossi,于2024年10月被任命为公司执行副总裁、首席财务官兼财务主管。Rossi女士于2009年12月加入Pediatrix,自那时起担任过各种高级会计、财务和财务职务,包括她最近担任的高级副总裁、财务报告和助理财务主管。在加入公司之前,从2003年7月到2009年12月,她曾在南佛罗里达州的上市公司担任多个会计和财务职务,包括Office Depot, Inc.(纳斯达克股票代码:ODP)和共和废品处理公司(纽约证券交易所股票代码:RSG)。Rossi女士曾于1999年9月至2003年7月担任Ernst & Young,LLP保险业务的成员,为包括医疗保健、私募股权和航空在内的多个行业的南佛罗里达州客户提供服务。Rossi女士拥有佛罗里达大西洋大学会计学理学学士学位。


Kasandra H. Rossi,was appointed to serve as the Company's Executive Vice President, Chief Financial Officer and Treasurer in October 2024. Ms. Rossi joined Pediatrix in December 2009 and has served in various senior-level accounting, finance and treasury roles since that time, including her most recent role as Senior Vice President, Financial Reporting and Assistant Treasurer. Prior to joining the Company, from July 2003 to December 2009, she served in various accounting and finance roles at public companies in South Florida, including Office Depot, Inc. (NASDAQ:ODP) and Republic Services, Inc. (NYSE:RSG). Ms. Rossi was previously a member of the assurance practice of Ernst & Young, LLP from September 1999 to July 2003, serving South Florida clients in a variety of industries including health care, private equity and aviation. Ms. Rossi holds a Bachelor of Science in Accounting from Florida Atlantic University.
Kasandra H. Rossi,于2024年10月被任命为公司执行副总裁、首席财务官兼财务主管。Rossi女士于2009年12月加入Pediatrix,自那时起担任过各种高级会计、财务和财务职务,包括她最近担任的高级副总裁、财务报告和助理财务主管。在加入公司之前,从2003年7月到2009年12月,她曾在南佛罗里达州的上市公司担任多个会计和财务职务,包括Office Depot, Inc.(纳斯达克股票代码:ODP)和共和废品处理公司(纽约证券交易所股票代码:RSG)。Rossi女士曾于1999年9月至2003年7月担任Ernst & Young,LLP保险业务的成员,为包括医疗保健、私募股权和航空在内的多个行业的南佛罗里达州客户提供服务。Rossi女士拥有佛罗里达大西洋大学会计学理学学士学位。
Kasandra H. Rossi,was appointed to serve as the Company's Executive Vice President, Chief Financial Officer and Treasurer in October 2024. Ms. Rossi joined Pediatrix in December 2009 and has served in various senior-level accounting, finance and treasury roles since that time, including her most recent role as Senior Vice President, Financial Reporting and Assistant Treasurer. Prior to joining the Company, from July 2003 to December 2009, she served in various accounting and finance roles at public companies in South Florida, including Office Depot, Inc. (NASDAQ:ODP) and Republic Services, Inc. (NYSE:RSG). Ms. Rossi was previously a member of the assurance practice of Ernst & Young, LLP from September 1999 to July 2003, serving South Florida clients in a variety of industries including health care, private equity and aviation. Ms. Rossi holds a Bachelor of Science in Accounting from Florida Atlantic University.
Mary Ann E. Moore

Mary Ann E. Moore于2024年8月被任命为首席行政官,此外她还于2022年10月被任命为执行副总裁、总法律顾问和秘书。Moore女士于2006年加入公司,担任协理总法律顾问,自那时起在法律部门担任多个高级职务。在加入公司之前,Moore女士是位于南佛罗里达州的泰尼特保健公司(NYSE:THC)的高级法律顾问。Moore女士此前在伊利诺伊州芝加哥市的Adventist Health System任职,在此之前,她在伊利诺伊州芝加哥市的Hinshaw和Culbertson律师事务所以及宾夕法尼亚州阿伦敦的Tallman Hudders和Sorrentino律师事务所从事私人法律业务。Moore女士拥有杜肯大学法学院的法学博士学位和卡洛学院的护理学学士学位,均位于宾夕法尼亚州匹兹堡。


Mary Ann E. Moore,was appointed as Chief Administrative Officer in August 2024, in addition to her existing appointment as Executive Vice President, General Counsel and Secretary in October 2022. Ms. Moore joined the Company in 2006 as Associate General Counsel and has served in various senior roles within the Legal Department since that time. Prior to joining the Company, Ms. Moore was Senior Counsel for Tenet Healthcare Corporation (NYSE:THC) in South Florida. Ms. Moore was previously with the Adventist Health System in Chicago, Illinois and prior thereto she was in private legal practice with the law firms of Hinshaw and Culbertson in Chicago, Illinois and Tallman Hudders and Sorrentino in Allentown, Pennsylvania. Ms. Moore holds a Juris Doctor degree from Duquesne University School of Law and a Bachelor of Science in Nursing degree from Carlow College, both in Pittsburgh, Pennsylvania.
Mary Ann E. Moore于2024年8月被任命为首席行政官,此外她还于2022年10月被任命为执行副总裁、总法律顾问和秘书。Moore女士于2006年加入公司,担任协理总法律顾问,自那时起在法律部门担任多个高级职务。在加入公司之前,Moore女士是位于南佛罗里达州的泰尼特保健公司(NYSE:THC)的高级法律顾问。Moore女士此前在伊利诺伊州芝加哥市的Adventist Health System任职,在此之前,她在伊利诺伊州芝加哥市的Hinshaw和Culbertson律师事务所以及宾夕法尼亚州阿伦敦的Tallman Hudders和Sorrentino律师事务所从事私人法律业务。Moore女士拥有杜肯大学法学院的法学博士学位和卡洛学院的护理学学士学位,均位于宾夕法尼亚州匹兹堡。
Mary Ann E. Moore,was appointed as Chief Administrative Officer in August 2024, in addition to her existing appointment as Executive Vice President, General Counsel and Secretary in October 2022. Ms. Moore joined the Company in 2006 as Associate General Counsel and has served in various senior roles within the Legal Department since that time. Prior to joining the Company, Ms. Moore was Senior Counsel for Tenet Healthcare Corporation (NYSE:THC) in South Florida. Ms. Moore was previously with the Adventist Health System in Chicago, Illinois and prior thereto she was in private legal practice with the law firms of Hinshaw and Culbertson in Chicago, Illinois and Tallman Hudders and Sorrentino in Allentown, Pennsylvania. Ms. Moore holds a Juris Doctor degree from Duquesne University School of Law and a Bachelor of Science in Nursing degree from Carlow College, both in Pittsburgh, Pennsylvania.